Levobupivacaine Solution for Injection/Infusion

Levobupivacaine Solution for Injection/Infusion
Product Description

Levobupivacaine is a long-acting local anaesthetic used for regional anaesthesia and pain management. It provides effective anaesthesia and analgesia across a wide range of clinical settings, including surgery and labour. With a similar efficacy profile to bupivacaine but lower cardiovascular and CNS toxicity, it offers a favourable safety profile. It is suitable for both bolus administration and continuous postoperative infusion.

Ethypharm

  • Country/Region:
    France
  • Founded:
    1977
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Contract Service
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (innovator finished products)
Specifications
  • Details
  • Active substance: Levobupivacaine
  • Form: Solution for injection and infusion
  • Strengths: 2.5 mg/mL, 5 mg/mL, 7.5 mg/mL
  • Route: Regional anaesthesia (epidural, intrathecal, nerve block)
  • Indications:
    • Major and minor surgical anaesthesia
    • Postoperative and labour pain management
    • Paediatric analgesia (ilioinguinal/iliohypogastric block)
  • Selling Points
  • Proven efficacy in regional anaesthesia
  • Long-acting analgesic effect
  • Lower cardiovascular and CNS toxicity vs bupivacaine
  • Suitable for surgical and labour pain
  • Model
    Levobupivacaine 2.5 mg/mL / 5 mg/mL / 7.5 mg/mL
  • Measured In
    milligram
  • Sales Markets

    Ethypharm

    • Country/Region:
      France
    • Founded:
      1977
    • On CPHI since:
      2015
    • Certificates:
      4
    • Employees:
      1000 - 4999
    Company types
    Contract Service
    Distributor/Import Export
    Manufacturer/Innovator
    Pharmaceutical company
    Primary activities
    Contract Manufacturer
    Custom Manufacturing/Custom Synthesis
    Pharmaceutical Company (innovator finished products)

    More Products from Ethypharm (62)

    • Fenofibrate 145 mg Tablets

      Product Fenofibrate 145 mg Tablets

      Fenofibrate Ethypharm 145 mg is a lipid-lowering medication designed to support the management of dyslipidaemia and reduce cardiovascular risk. It is indicated as an adjunct to diet and lifestyle modifications for the treatment of severe hypertriglyceridaemia and mixed hyperlipidaemia. The formulation util...
    • Fentanyl Citrate 50 μg/ml

      Product Fentanyl Citrate 50 μg/ml

      Analgesia for short surgical procedures at lowdoses.Analgesia with assisted ventilation at high doses.Treatment of severe pain
    • Fentanyl Sublingual tablet

      Product Fentanyl Sublingual tablet

      Breakthrough pain in opioid therapy for chronic cancer pain
    • Glycopyrronium Bromide 200 μg/ml

      Product Glycopyrronium Bromide 200 μg/ml

      To reduce salivary, tracheobronchial and pharyngeal secretion
    • Ibuprofen Bag

      Product Ibuprofen Bag

      Short-term symptomatic treatment of acute moderate pain
    • Levetiracetam 100 mg/mL

      Product Levetiracetam 100 mg/mL

      Mono- and adjunctive therapy of epilepsy
    • Levofloxacin Hemihydrate 5 mg/ml

      Product Levofloxacin Hemihydrate 5 mg/ml

      Treatment of the infections, caused by micro-or100ml ganisms sensitive to levofloxacin
    • Magnesium Sulfate

      Product Magnesium Sulfate

      0.5 g/ml: Treatment of magnesium deficiency; To preventfurther seizures associated with eclampsia
      150 mg/ml: Magnesium supplementation during electrolytere-balancing: treatment of hypomagnesaemiaand treatment of acute hypokalaemia associatedwith hypomagnesaemia.Magnesium supplementation in parenteraln...
    • Mesna

      Product Mesna

      100 mg/ml: Prevention of urothelial toxicity in patients treatedwith oxazaphosphorines

      200 mg/ml: Solution for infusion & endotracheopulmonaryinstillation
    • Morphine Sulfate Ampoule

      Product Morphine Sulfate Ampoule

      For the relief of severe pain
    • Morphine Sulfate Orodispersible tablet
    • Morphine Sulphate Oral Solution

      Product Morphine Sulphate Oral Solution

      Morphine Sulphate Oral Solution 10 mg/5 mL is a clear liquid formulation indicated for the relief of severe pain. Containing morphine sulfate pentahydrate, it is designed for oral administration and provides reliable and flexible dosing for both adult and paediatric patients when prescribed appropriately. ...

    Ethypharm resources (1)